Results 191 to 200 of about 111,213 (213)

Commercial Determinants of Health: Economic and Health Interests Can Be Aligned. [PDF]

Port J Public Health
Perelman J.
europepmc   +1 more source

The 40% weight-reduction craze: market volatility, metabolic nuance, and the quest for sustainable health. [PDF]

Mol Cells
Han W, Shepherd P, Ueki K, Li J, Xu A, Oh G, Kim JB.   +6 more
europepmc   +1 more source

Nutraceutical market in India: Thoughts on a right-based regulatory approach.

Indian J Pharmacol
Haripriya G, Harigovind PC, Sankar UV.
europepmc   +1 more source

Universal Coverage without Financial Protection: Why Out-of-Pocket Payments Persist Despite Universal Coverage in Georgia

Tvaliashvili M, Sulaberidze L, Gotsadze G, Goodman C, Hanson K.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmaceuticals Market, Consumption Trends and Disease Incidence Are Not Driving the Pharmaceutical Research on Water and Wastewater

International Journal of Environmental Research and Public Health, 2021
Omar Israel González Pena, MIGUEL Ángel López Zavala, Hector Cabral Ruelas   +2 more
exaly  

Development of Pharmaceutical Nanomedicines: From the Bench to the Market

Pharmaceutics, 2022
Abdulrahman A Halwani
exaly  

Decision analysis on entering the China pharmaceutical market: Perspectives from Taiwanese companies

Computers and Industrial Engineering, 2018
Jei-Zheng Wu, Yu-Chen Hsu
exaly  

A research note on market creation in the pharmaceutical industry

Journal of Business Research, 2011
Jenny Darroch, Morgan P Miles
exaly  

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries

DARU, Journal of Pharmaceutical Sciences, 2013
Abbas Kebriaeezadeh, Akbar Abdollahiasl, Shekoufeh Nikfar   +2 more
exaly  

Dual market structures and the likelihood of repeated ties – evidence from pharmaceutical biotechnology

Research Policy, 2005
Nadine Roijakkers, John Hagedoorn, Hans Van Kranenburg   +2 more
exaly